上海医药：关于2019年A股股票期权激励计划预留股票期权第三个行权期限制行权期间的提示性公告

Core Points - Shanghai Pharmaceuticals announced the restriction period for the third exercise phase of its 2019 stock option incentive plan, which will run from October 1, 2025, to October 30, 2025 [1] - The third exercise phase is set to begin on February 8, 2025, and will end on February 7, 2026 [1] - The company will apply to the China Securities Depository and Clearing Corporation Limited Shanghai Branch for the relevant matters regarding the restriction on exercise [1]